Colchicine overdose impairs the capacity of Kupffer cells to clear foreign particles and endotoxins.
Drug toxicity
Intravital imaging
Lipopolysaccharide
Microtubules
Phagocytosis
Journal
Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
25
05
2022
accepted:
01
08
2022
pubmed:
15
9
2022
medline:
5
10
2022
entrez:
14
9
2022
Statut:
ppublish
Résumé
Colchicine is an anti-inflammatory drug with a narrow therapeutic index. Its binding to tubulin prevents microtubule polymerization; however, little is known about how depolymerization of microtubules interferes with the phagocytosis function of Kupffer cells (KC). Here, we applied functional intravital imaging techniques to investigate the influence of microtubule disruption by colchicine on KC morphology, as well as its capacity to clear foreign particles and bacterial lipopolysaccharide (LPS) in anesthetized mice. Intravital imaging of KC in healthy mice showed the typical elongated morphology, localization at the luminal side of the sinusoidal endothelial cells, and moving cell protrusions. In contrast, at colchicine doses of 1 mg/kg and higher (intraperitoneal), KC appeared roundish with strongly reduced protrusions and motility. To study the functional consequences of these alterations, we analyzed the capacity of KC to phagocytose fluorescent nanospheres (100 nm-size) and LPS. After tail vein injection, the nanospheres formed aggregates of up to ~ 5 µm moving along the sinusoidal bloodstream. In controls, the nanosphere aggregates were rapidly captured by the Kupffer cell protrusions, followed by an internalization process that lasted up to 10 min. Similar capture events and internalization processes were observed after the administration of fluorescently labeled LPS. In contrast, capture and internalization of both nanospheres and LPS by KC were strongly reduced in colchicine-treated mice. Reduced phagocytosis of LPS was accompanied by aggravated production of inflammatory cytokines. Since 0.4 mg/kg colchicine in mice has been reported to be bio-equivalent to human therapeutic doses, the here-observed adverse effects on KC occurred at doses only slightly above those used clinically, and may be critical for patients with endotoxemia due to a leaky gut-blood barrier.
Identifiants
pubmed: 36102954
doi: 10.1007/s00204-022-03353-8
pii: 10.1007/s00204-022-03353-8
pmc: PMC9525399
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Cytokines
0
Endotoxins
0
Lipopolysaccharides
0
Tubulin
0
Colchicine
SML2Y3J35T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3067-3076Informations de copyright
© 2022. The Author(s).
Références
Arthritis Rheum. 1976 May-Jun;19(3):618-22
pubmed: 779797
Arch Toxicol. 2021 Jun;95(6):2163-2177
pubmed: 34003344
Front Pharmacol. 2019 Aug 16;10:908
pubmed: 31474864
Arch Toxicol. 2017 Mar;91(3):1335-1352
pubmed: 27999878
Nat Metab. 2021 Apr;3(4):513-522
pubmed: 33846641
Hepatology. 2019 Feb;69(2):666-683
pubmed: 30102412
Front Cell Dev Biol. 2021 Apr 29;9:633925
pubmed: 33996793
Genesis. 2007 Sep;45(9):593-605
pubmed: 17868096
Arch Toxicol. 2021 Feb;95(2):573-589
pubmed: 33106934
Cells. 2019 Dec 02;8(12):
pubmed: 31810365
Hepatology. 2009 Dec;50(6):2022-33
pubmed: 19885876
Arch Toxicol. 2020 Jan;94(1):205-217
pubmed: 31919559
Gut Liver. 2021 Sep 15;15(5):666-676
pubmed: 33071239
Front Immunol. 2018 Sep 04;9:1991
pubmed: 30233585
Transgenic Res. 1999 Aug;8(4):265-77
pubmed: 10621974
Cell Rep. 2021 Aug 24;36(8):109526
pubmed: 34433051
Clin Ther. 2014 Oct 1;36(10):1465-79
pubmed: 25151572
Cells. 2021 Sep 23;10(10):
pubmed: 34685496
EXCLI J. 2016 Dec 23;15:872-874
pubmed: 28275323
Semin Arthritis Rheum. 2015 Dec;45(3):341-50
pubmed: 26228647
Cell Mol Gastroenterol Hepatol. 2021;11(4):909-933
pubmed: 33189892
Hepatology. 2022 May;75(5):1095-1109
pubmed: 34927748
J Hepatol. 2022 Jul;77(1):71-83
pubmed: 35131407
Compr Physiol. 2013 Apr;3(2):785-97
pubmed: 23720329
Contrib Nephrol. 2010;167:14-24
pubmed: 20519895
Chem Biol Interact. 2022 Jan 5;351:109728
pubmed: 34717914
Hepatology. 2021 Apr;73(4):1531-1550
pubmed: 32558958
Clin Toxicol (Phila). 2010 Jun;48(5):407-14
pubmed: 20586571
Hepatol Commun. 2022 Jan;6(1):161-177
pubmed: 34558834
Nat Metab. 2021 Sep;3(9):1228-1241
pubmed: 34552267